High-intensity aerobic exercise improves both hepatic fat content and stiffness in sedentary obese men with nonalcoholic fatty liver disease

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Oh, Sechang ^a,b,c   So, Rina ^c,d   Shida, Takashi ^b   Matsuo, Tomoaki ^d   Kim, Bokun ^e   Akiyama, Kentaro ^b,c   Isobe, Tomonori ^b   Okamoto, Yoshikazu ^b   Tanaka, Kiyoji ^b   Shoda, Junichi ^a,b  

^a UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^d NATIONAL INSTITUTE OF OCCUPATIONAL SAFETY AND HEALTH   (Japan)

^e Inje University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID SYNTHASE; FERRITIN; LEPTIN;

COMPLICATION; CYTOLOGY; DIAGNOSTIC IMAGING; DIFFUSION TENSOR IMAGING; ECHOGRAPHY; EXERCISE; GENETICS; HUMAN; IMMUNOLOGY; INTRA-ABDOMINAL FAT; KUPFFER CELL; LIPID METABOLISM; LIVER; MALE; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOLOGY; PHYSIOLOGY; RESISTANCE TRAINING;

DIFFUSION TENSOR IMAGING; EXERCISE; FATTY ACID SYNTHASES; FERRITINS; HUMANS; INTRA-ABDOMINAL FAT; KUPFFER CELLS; LEPTIN; LEUKOCYTES, MONONUCLEAR; LIPID METABOLISM; LIVER; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; RESISTANCE TRAINING; ULTRASONOGRAPHY;

EID: 85013683287     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep43029     Document Type: Article

References (50)

1. Gastaldelli, A. et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology 133, 496-506 (2007).
2. Jakobsen, M. U., Berentzen, T., Sorensen, T. I. & Overvad, K. Abdominal obesity and fatty liver. Epidemiol Rev 29, 77-87 (2007).
3. Bhatia, L. S., Curzen, N. P., Calder, P. C. & Byrne, C. D. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?Eur Heart J 33, 1190-1200 (2012).
4. Arase, Y. et al. Multivariate analysis of risk factors for the development of type 2 diabetes in nonalcoholic fatty liver disease. J Gastroenterol 44, 1064-1070 (2009).
5. Johnson, N. A. et al. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 50, 1105-1112 (2009).
6. St George, A. et al. Independent effects of physical activity in patients with nonalcoholic fatty liver disease. Hepatology 50, 68-76 (2009).
7. Perseghin, G. et al. Habitual physical activity is associated with intrahepatic fat content in humans. Diabetes care 30, 683-688 (2007).
8. Nguyen-Duy, T. B., Nichaman, M. Z., Church, T. S., Blair, S. N. & Ross, R. Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am J Physiol Endocrinol Metab 284, E1065-1071 (2003).
9. Kantartzis, K. et al. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Gut 58, 1281-1288 (2009).
10. Fabbrini, E., Sullivan, S. & Klein, S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51, 679-689 (2010).
11. Sreenivasa Baba, C. et al. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. J Gastroenterol Hepatol 21, 191-198 (2006).
12. Keating, S. E., Hackett, D. A., George, J. & Johnson, N. A. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 57, 157-166 (2012).
13. Donnelly, J. E. et al. American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 41, 459-471 (2009).
14. Oh, S. et al. Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: a retrospective study. Hepatology 61, 1205-1215 (2015).
15. Hallsworth, K. et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 60, 1278-1283 (2011).
16. Bacchi, E. et al. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial). Hepatology 58, 1287-1295 (2013).
17. Vilar Gomez, E. et al. Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther 30, 999-1009 (2009).
18. Ibanez, J. et al. Twice-weekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes. Diabetes care 28, 662-667 (2005).
19. DiPietro, L., Dziura, J., Yeckel, C. W. & Neufer, P. D. Exercise and improved insulin sensitivity in older women: evidence of the enduring benefits of higher intensity training. J Appl Physiol 100, 142-149 (2006).
20. Matsuo, T. et al. Effects of a low-volume aerobic-type interval exercise on VO2max and cardiac mass. Med Sci Sports Exerc 46, 42-50 (2014).
21. Wisloff, U. et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 115, 3086-3094 (2007).
22. Matsuo, T., So, R., Shimojo, N. & Tanaka, K. Effect of aerobic exercise training followed by a low-calorie diet on metabolic syndrome risk factors in men. Nutr Metab Cardiovasc Dis 25, 832-838 (2015).
23. Kanazawa, M. et al. Criteria and classification of obesity in Japan and Asia-Oceania. World Rev Nutr Diet 94, 1-12 (2005).
24. Farrell, G. C., Chitturi, S., Lau, G. K. & Sollano, J. D. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 22, 775-777 (2007).
25. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc 41, 687-708 (2009).
26. Matsuo, T. et al. Cardiorespiratory fitness level correlates inversely with excess post-exercise oxygen consumption after aerobic-type interval training. BMC Research Notes 5, 1-4 (2012).
27. So, R. et al. Best single-slice measurement site for estimating visceral adipose tissue volume after weight loss in obese, Japanese men. Nutr Metab 9, 56 (2012).
28. Sandrin, L. et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 29, 1705-1713 (2003).
29. Sasso, M. et al. Controlled attenuation parameter (CAP): a novel VCTE guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 36, 1825-1835 (2010).
30. Oh, S. et al. Acceleration training for managing nonalcoholic fatty liver disease: a pilot study. Ther Clin Risk Manag 10, 925-936 (2014).
31. Yanagisawa, K., Moriyasu, F., Miyahara, T., Yuki, M. & Iijima, H. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 33, 318-325 (2007).
32. Iijima, H. et al. Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis. Hepatol Res 37, 722-730 (2007).
33. Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419 (1985).
34. Angulo, P. et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 45, 846-854 (2007).
35. Bouwens, M., Grootte Bromhaar, M., Jansen, J., Muller, M. & Afman, L. A. Postprandial dietary lipid-specific effects on human peripheral blood mononuclear cell gene expression profiles. Am J Clin Nutr 91, 208-217 (2010).
36. Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860-867 (2006).
37. Karlas, T. et al. Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy. PloS one 9, e91987 (2014).
38. Donnelly, K. L. et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115, 1343-1351 (2005).
39. Yoneda, M. et al. Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology 256, 640-647 (2010).
40. Obara, N. et al. Transient elastography for measurement of liver stiffness measurement can detect early significant hepatic fibrosis in Japanese patients with viral and nonviral liver diseases. J Gastroenterol 43, 720-728 (2008).
41. Wong, V. W. et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology 51, 454-462 (2010).
42. Mueller, S. & Sandrin, L. Liver stiffness: a novel parameter for the diagnosis of liver disease. Hepat Med 2, 49-67 (2010).
43. Kistler, K. D. et al. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am J Gastroenterol 106, 460-468 (2011).
44. Oh, S., Tanaka, K., Warabi, E. & Shoda, J. Exercise reduces inflammation and oxidative stress in obesity-related liver diseases. Med Sci Sports Exerc 45, 2214-2222 (2013).
45. Yanagisawa, K. et al. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 33 318-325 (2007).
46. Yoshikawa, S. et al. Crucial role of impaired Kupffer cell phagocytosis on the decreased Sonazoid-enhanced echogenicity in a liver of a nonalchoholic steatohepatitis rat model. Hepatol Res 40, 823-831 (2010).
47. Stewart, L. K. et al. Influence of exercise training and age on CD14+ cell-surface expression of toll-like receptor 2 and 4. Brain Behav Immun 19, 389-397 (2005).
48. Fernandez-Gonzalo, R. et al. TLR4-Mediated Blunting of Inflammatory Responses to Eccentric Exercise in Young Women. Mediat Inflamm 2014, 11 (2014).
49. Kim, S.-Y., Lee, Y.-S. & Surh, Y.-J. Adaptive Redox Response to Oxidative Challenge during Exercise: Potential Roles of Nrf2 and HO-1. The FASEB Journal 25, 1107.1111 (2011).
50. Kobayashi, E. H. et al. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat Commun 7, 11624 (2016).